Warfarin Sodium
Product Images NDC 70934-820

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Warfarin Sodium (NDC 70934-820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 820 30 Master Bottle Label Approval Rev A 01 21)

Label (70934 820 30 Master Bottle Label Approval   Rev A 01 21)
Label for Warfarin Sodium Tablets, USP 1 mg, containing 30 tablets. The label indicates prescription use only, storage instructions between 20°C to 25°C with allowed excursions, and includes warnings about dosage and light protection. The product is labeled by Denton Pharma, Inc. DBA Northwind Pharmaceuticals and displays the NDC 70934-820-30.*
FDA Label Image

474ff828-figure-01 (Warfarin Sodium Tablets Usp 1)

474ff828-figure-01 (Warfarin Sodium Tablets Usp 1)
Chemical structure diagram of Warfarin Sodium, showing its molecular arrangement with benzene rings and functional groups including sodium carboxylate and ketone moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.